Fig. 3From: Associations of quantitative whole-body PSMA-PET metrics with PSA progression status under long-term androgen deprivation therapy in prostate cancer patients: a retrospective single-center studyWaterfall plots depicting the relationship between percent changes in WB-PSMA-VOL and PSA progression status at PET2 (a), percent changes in WB-PSMA-SUVmean and PSA progression status at PET2 (b), and percent changes in PSA and RECIP 1.0 progression status (c)Back to article page